Molecular Matrix, Inc.
PrivateLast Round
Angel
Jan 11, 2018
Total Funding Raised
$855,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Molecular Matrix, Inc. is a biotechnology company that develops and provides solutions in bone regeneration, tissue engineering, and regenerative medicine. The company's main product is Osteo-P® BGS, a synthetic, non-mineralized bone graft substitute used in orthopedic, spine, and trauma applications to support and guide the ingrowth of new bone.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Molecular Matrix, Inc. Comparables
Compare Molecular Matrix, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cerapedics | 85% | |
| OssDsign | 81% | |
| Bone Biologics Corporation | 78% |
Molecular Matrix, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Jan 11, 2018 |
Molecular Matrix, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UC Davis Health Ventures | Angel |
| Shasta Angel Group | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 39% MoM, reaching 1.6K.
- Feb 1, 2026
Monthly visitors increased 41% MoM.
Molecular Matrix, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Molecular Matrix, Inc.'s valuation, stock price, and market status.
Is Molecular Matrix, Inc. a public or private company?
Molecular Matrix, Inc. is a private company.
What is the current stock price of Molecular Matrix, Inc.?
Molecular Matrix, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Molecular Matrix, Inc. worth (valuation)?
Valuation information for Molecular Matrix, Inc. is not publicly available.
Can I buy Molecular Matrix, Inc. stock?
Molecular Matrix, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Molecular Matrix, Inc.'s last funding round?
Molecular Matrix, Inc.'s most recent funding round was Angel on January 11, 2018.
Who are the main investors in Molecular Matrix, Inc.?
Key investors in Molecular Matrix, Inc. include UC Davis Health Ventures, Shasta Angel Group.
Will Molecular Matrix, Inc. IPO soon?
No public IPO plans have been announced for Molecular Matrix, Inc..
How can I track Molecular Matrix, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Molecular Matrix, Inc.'s secondary market activity and sign up for updates.